Details for New Drug Application (NDA): 021543
✉ Email this page to a colleague
The generic ingredient in STRIANT is testosterone. There are sixty-nine drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the testosterone profile page.
Summary for 021543
Tradename: | STRIANT |
Applicant: | Auxilium Pharms Llc |
Ingredient: | testosterone |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 021543
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;BUCCAL | Strength | 30MG | ||||
Approval Date: | Jun 19, 2003 | TE: | RLD: | Yes |
Expired US Patents for NDA 021543
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Auxilium Pharms Llc | STRIANT | testosterone | TABLET, EXTENDED RELEASE;BUCCAL | 021543-001 | Jun 19, 2003 | ⤷ Sign Up | ⤷ Sign Up |
Auxilium Pharms Llc | STRIANT | testosterone | TABLET, EXTENDED RELEASE;BUCCAL | 021543-001 | Jun 19, 2003 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription